Healthcare >> CEO Interviews >> December 14, 1998
MICHAEL J. BRENNAN, M.D., Ph.D., joined the Company as its President and
Chief Executive Officer in December 1995 and was appointed to the Board
of Directors as of that date. From October 1993 to November 1995, he was
Vice President, Business Development for Corange International Limited's
worldwide therapeutics business (Boehringer Mannheim Therapeutics).
Prior to that, Dr. Brennan was a director and the general manager of
Boehringer Mannheim South Africa. He served from October 1989 to June
1990 as divisional manager for the hospital business of Johnson &
Johnson and as medical director of Cilag (Pty.) Ltd., a subsidiary of
Johnson & Johnson. Dr. Brennan was the founder of Chronotech Corp.,
consultants to industry on shift work scheduling, and Molemed
International, a medical device company. He is the inventor of Molemed's
sole product, which is marketed in five countries. Dr. Brennan received
a Ph.D. in Neurobiology and a M.D. from the University of the
Witwatersrand, Johannesburg, South Africa. In 1985, he completed his
residency in neurology at Harvard Medical School and Boston City
Hospital. Profile
activities?
Dr. Brennan: Gene Logic is a genomics and bioinformatics company, so
what we do is to generate sets of data based
